A global CDMO driven by expertise, partnership, and helping patients
Bora Pharmaceuticals is a contract development and manufacturing organization (CDMO) guided by our dedication to reliable execution and on-time, in-full delivery. We partner with pharmaceutical companies worldwide to bring complex therapies to market, combining deep technical expertise with a disciplined, performance-driven approach to pharmaceutical production.
From early-stage programs through commercial production and packaging, our teams focus on consistency, quality, and supply continuity. With capabilities spanning oral solid dosage forms, biologics, liquids, semi-solids, powders, and sterile injectables, we help ensure that critical medicines are delivered where and when they are needed.
How we work
Bora treats every project as a shared endeavor and takes responsibility for seeing it through to completion, on time and in full. We understand that timelines are a blueprint for pharmaceutical programs’ overall success, impacting everything from budget to regulatory compliance to market competition. We set ourselves apart in the highly competitive CDMO landscape with a proven, industry-leading track record of on-time, in-full, right-first-time delivery. It is our goal to foster complete confidence and provide total satisfaction.
Our global presence
Bora Pharmaceuticals operates a global network of nine sites across Asia and North America, supporting the delivery of therapies to more than 100 markets worldwide. This footprint is designed to ensure reliable supply across regions, with the flexibility to support programs from early development through commercial manufacturing. By aligning operations, quality systems, and technical expertise across sites, Bora delivers a consistent standard of execution, quality, and supply continuity regardless of manufacturing location.
Whether supporting regional distribution or global product launches, our teams remain focused on delivering continuity of supply and meeting commitments to partners and patients without disruption.
Milestones
Our journey to becoming a global CDMO
Our pledge to partners
We are driven by a shared commitment to supply patients with the best possible products, so our responsibility does not end when a shipment leaves our site. It extends to the patient. This big-picture view shapes our approach to every project and fuels our dedication to continuous improvement.
The Bora Pledge represents five key principles that guide our organization across every team, every site, and every project:
Promises
In an industry of uncertainty, too many CDMOs overpromise and underdeliver. At Bora Pharmaceuticals, we approach every program with transparency and flexibility to ensure we can do what we say we’ll do, when we say we’ll do it.
Partnerships
Bora treats every project as a shared endeavor and takes responsibility for seeing it through to completion, on time and in full. Rather than chasing short-term, transactional wins, we seek to foster sustainable, resilient relationships built on trust and shared goals.
Pride
For CDMO services, high quality is table stakes. As a business and as people, we take immense pride in what we do. We go above and beyond to execute quality manufacturing with unparalleled reliability and attention to detail.
People
An organization is only as strong as its people. Our culture and the caliber of those who represent us is something we take more seriously than most — for us, success truly is personal.
Progress
Unprecedented regulations, advances, and changes affect today’s pharmaceutical industry. At Bora Pharmaceuticals, we’re set on building a business and culture fit for the future, defined by continuous improvement, growing capabilities, and alignment with the long-term needs of our customers.
Our commitment to sustainability
Guided by our mission, “Contributing to Better Health All Over the World,” we actively advance sustainability strategies, address stakeholder priorities, and pursue balanced growth across economic, social, and environmental dimensions.
